A new approach for early breast cancer patients to follow up during hormonal treatment.

Better care. Closer to patients. Connected support.

WISH is a European research project developing and testing a new model of follow-up for women receiving hormonal treatment after early breast cancer. It connects women, general practitioners and oncology teams through a shared care pathway supported by digital tools.

Discover WISH approach Latest news

Why WISH

Hormonal treatment after early breast cancer may continue for several years. During this period, women may experience physical, emotional and practical challenges that affect treatment adherence, well-being and everyday life. Follow-up is often centred on periodic hospital appointments, while many needs arise between visits.

WISH is exploring a more connected approach in which women, general practitioners and oncology teams work together throughout follow-up.

4 Key Pillars of the Project

Connected Care

A shared pathway for patients, primary care professionals and oncology teams.

Closer to home

At-home follow-up through a secure intelligent system tested in two countries: Italy and Spain.

Earlier support

Report symptoms, treatment-related effects and changes in well-being between scheduled appointments.

Personalised Lifestyle guidence

Tailored information and support related to physical, emotional and social aspects of well-being.

Project Partners

Federico Sottotetti

ICS Maugeri (ICSM),

Medical Oncology Unit

Pavia, Italy

Silvana Quaglini

University of Pavia (UNIPV)

Pavia, Italy

Cesar Agostinis Sobrinho

Klaipėda University (KU)

Klaipėda, Lithuania

Mara Gabriela Diaconu

Norwegian University of Science and Technology (NTNU)

Trondheim, Norway

Marilina García-Aranda

Foundation for Biomedical and Health Research of Málaga-Hospital Universitario Costa del Sol (FIMABIS-HUCS)

Malaga, Spain

Michel Deriaz

Haute Ecole Spécialisée de Suisse Occidentale (HES-SO)

Geneva, Switzerland

David Beni

arx iT Consulting SA (ARX)

Geneva, Switzerland

Fast recovery begins with better patient follow-up.